CoChat

Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury

Open access
Zhong, Lin, Wang, Jingjing, Wang, Peng, Liu, Xiaoyin, Liu, Peng, Cheng, Xu, Cao, Lujia, Wu, Hongwei, Chen, Jing, Zhou, Liangxue · 2023 · Stem Cell Research & Therapy

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Abstract

Regenerative repair of the brain after traumatic brain injury (TBI) remains an extensive clinical challenge, inspiring intensified interest in therapeutic approaches to explore superior repair strategies. Exosome therapy is another research hotspot following stem cell alternative therapy. Prior research verified that exosomes produced by neural stem cells can participate in the physiological and pathological changes associated with TBI and have potential neuroregulatory and repair functions. In comparison with their parental stem cells, exosomes have superior stability and immune tolerance and lower tumorigenic risk. In addition, they can readily penetrate the blood‒brain barrier, which makes their treatment efficiency superior to that of transplanted stem cells. Exosomes secreted by neural stem cells present a promising strategy for the development of novel regenerative therapies. Their tissue regeneration and immunomodulatory potential have made them encouraging candidates for TBI repair. The present review addresses the challenges, applications and potential mechanisms of neural stem cell exosomes in regenerating damaged brains.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-023-03409-1

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic diagram of cellular communication between NSC exosomes and the surrounding microenvironment. NSC exosomes may exert their effects by acting on surrounding cells. For example, NSC-derived exosomes, especially miR-9, facilitate the differentiation of NSCs into neurons, oligodendrocytes and astrocytes by repressing Hes1. Moreover, miR-150-3p secreted by exosomes prevents neuronal apoptosis by targeting CASP2, or a high level of miR-21a can promote the differentiation of NSCs into neurons, which causes glial scar reduction
Fig. 1 Schematic diagram of cellular communication between NSC exosomes and the surrounding microenvironment. NSC exosomes may exert their effects by acting on surrounding cells. For example, NSC-derived exosomes, especially miR-9, facilitate the differentiation of NSCs into neurons, oligodendrocytes and astrocytes by repressing Hes1. Moreover, miR-150-3p secreted by exosomes prevents neuronal apoptosis by targeting CASP2, or a high level of miR-21a can promote the differentiation of NSCs into neurons, which causes glial scar reductionCC BY · PubMed Central
Fig. 2 Schematic representation of exosome biosynthesis and ligand receptor binding. First, the cytoplasmic membrane, together with extracellular cargos, undergoes intracellular endocytosis from an early endosome. Late endosomes will next be generated through acidification and substance exchange of early endosomes. Late endosomes can eventually form MVBs. Ultimately, the multivesicular body will either fuse with lysosomes to degrade substances or fuse with the cell membrane to secrete exosomes into the extracellular space. Exosomes comprise a cargo of miRNAs, mRNAs, surface protein markers, including TSG101 and Alix, and the membrane markers CD9, CD63 and CD81. The released exosomes may affect the function of neighbouring and distant cells through several different mechanisms of action. One is that exosome membrane surface ligands bind to receptors on the receiving cell membrane, activating receptor-mediated signal transduction pathways, and the activated recipient cells ingest the contents into the cell through endocytosis. The other is that the receiving cell directly ingests exosomes into the cell in an endocytic manner, and the exosome contents are released into the cell. The last type is the direct fusion of the exosome membrane with the cell membrane, releasing the exosome contents into the cytoplasm
Fig. 2 Schematic representation of exosome biosynthesis and ligand receptor binding. First, the cytoplasmic membrane, together with extracellular cargos, undergoes intracellular endocytosis from an early endosome. Late endosomes will next be generated through acidification and substance exchange of early endosomes. Late endosomes can eventually form MVBs. Ultimately, the multivesicular body will either fuse with lysosomes to degrade substances or fuse with the cell membrane to secrete exosomes into the extracellular space. Exosomes comprise a cargo of miRNAs, mRNAs, surface protein markers, including TSG101 and Alix, and the membrane markers CD9, CD63 and CD81. The released exosomes may affect the function of neighbouring and distant cells through several different mechanisms of action. One is that exosome membrane surface ligands bind to receptors on the receiving cell membrane, activating receptor-mediated signal transduction pathways, and the activated recipient cells ingest the contents into the cell through endocytosis. The other is that the receiving cell directly ingests exosomes into the cell in an endocytic manner, and the exosome contents are released into the cell. The last type is the direct fusion of the exosome membrane with the cell membrane, releasing the exosome contents into the cytoplasmCC BY · PubMed Central
Fig. 3 A schematic of the possible mechanisms of exosomes secreted by NSCs for TBI therapeutic effects. Exosomes secreted by NSCs contain numerous active ingredients of cells, can cross the BBB freely, inhibit the inflammatory response and neuronal apoptosis, promote neuroregeneration and angiogenesis, etc. In response to neuroregeneration, NSCs secrete exosomes that contain circAcbd6 and further promote the differentiation of NSCs into cholinergic neurons via the miR-320-5p/oxysterol-binding protein–related protein 2 axis. NSC-derived exosomes contain components that inhibit the inflammatory response, downregulate the expression of proinflammatory factors such as TNF-α, IL-1 and IL-6 and promote microglial polarization from the M1 to M2 phenotypes. Upon anti-apoptosis, exosomes secreted by NSCs transfer miR-150-3p, an enriched miRNA, and suppress neuronal apoptosis. Increased expression of the autophagy marker proteins LC3B and beclin-1 caused by NSC exosomes also reduced apoptosis of nerve cells. For the promotion of angiogenesis, neural stem cell exosomes can upregulate VEGF levels, which in turn accelerate angiogenesis. Schematic created with CINEMA 4D
Fig. 3 A schematic of the possible mechanisms of exosomes secreted by NSCs for TBI therapeutic effects. Exosomes secreted by NSCs contain numerous active ingredients of cells, can cross the BBB freely, inhibit the inflammatory response and neuronal apoptosis, promote neuroregeneration and angiogenesis, etc. In response to neuroregeneration, NSCs secrete exosomes that contain circAcbd6 and further promote the differentiation of NSCs into cholinergic neurons via the miR-320-5p/oxysterol-binding protein–related protein 2 axis. NSC-derived exosomes contain components that inhibit the inflammatory response, downregulate the expression of proinflammatory factors such as TNF-α, IL-1 and IL-6 and promote microglial polarization from the M1 to M2 phenotypes. Upon anti-apoptosis, exosomes secreted by NSCs transfer miR-150-3p, an enriched miRNA, and suppress neuronal apoptosis. Increased expression of the autophagy marker proteins LC3B and beclin-1 caused by NSC exosomes also reduced apoptosis of nerve cells. For the promotion of angiogenesis, neural stem cell exosomes can upregulate VEGF levels, which in turn accelerate angiogenesis. Schematic created with CINEMA 4DCC BY · PubMed Central
Fig. 4 Preparation strategies for engineered exosomes: cell engineering and exosome engineering. Bioengineering of exosomal parent cells mainly includes genetic engineering, coincubation of parental cells with drugs and changes in cell culture conditions. Exosome engineering adopts specific techniques to directly modify the surface proteins or cargos of purified natural exosomes, including incubation, physical modification, saponification and surface modification. Among them, physical methods are divided into ultrasound, electroporation and freeze‒thaw, and surface modification is divided into covalent modification represented by click chemistry and noncovalent modification represented by electrostatic interactions and acceptor–ligand binding. Schematic created with CINEMA 4D
Fig. 4 Preparation strategies for engineered exosomes: cell engineering and exosome engineering. Bioengineering of exosomal parent cells mainly includes genetic engineering, coincubation of parental cells with drugs and changes in cell culture conditions. Exosome engineering adopts specific techniques to directly modify the surface proteins or cargos of purified natural exosomes, including incubation, physical modification, saponification and surface modification. Among them, physical methods are divided into ultrasound, electroporation and freeze‒thaw, and surface modification is divided into covalent modification represented by click chemistry and noncovalent modification represented by electrostatic interactions and acceptor–ligand binding. Schematic created with CINEMA 4DCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 119 references

Cited by

See all 119

Metadata

Authors
Zhong, L., Wang, J., Wang, P., Liu, X., Liu, P., Cheng, X., Cao, L., Wu, H., Chen, J., & Zhou, L.
Affiliations
  • First Affiliated Hospital of Chengdu Medical College (CN)
  • Tianjin Hospital (CN)
  • Sichuan University (CN)
  • Chengdu Medical College (CN)
Corresponding author
  • Wu, Hongwei
  • Chen, Jing
  • Zhou, Liangxue
Venue
Stem Cell Research & Therapy
Published
2023-08-08
Volume
14
Issue
1
Pages
198-198
ISSN
1757-6512 (ISSN-L)
OpenAlex
W4385664550
Cited by
110
References
119
Citations by year
2026: 34 · 2025: 40 · 2024: 34 · 2023: 2
FWCI
2.96
Type
journal article
Language
en
Open access
Licence
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
the National Major Scientific and Technological Special Project for Significant New Drugs Development (2019ZX09301-147)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
traumatic brain injury, cell-free therapy, nerve regeneration, blood-brain barrier penetration, immunomodulation, exosome stability, tumorigenicity, regenerative medicine
MeSH terms
Brain Injuries, Traumatic, Brain, Brain Injuries, Humans, Exosomes, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury. https://app.cochat.ai/papers/10.1186/s13287-023-03409-1
The paper
Zhong, L., Wang, J., Wang, P., Liu, X., Liu, P., Cheng, X., Cao, L., Wu, H., Chen, J., & Zhou, L. (2023). Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-023-03409-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.